Thus, it seems logical to assume that as CN reduces Aβ burden, this may reduce AChE activity, which is of particular significance given that ChAT activity remained unaltered in both vehicle- and CN-treated 3xTg-AD mice. The gene discussed is ACHE; the disease is Alzheimer disease.